• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PAH111002E
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 08/03/2018
Event Type  Injury  
Manufacturer Narrative
As the device remains implanted, an investigation on the device cannot be performed.Date of event was determined as date when literature article was accepted, here (b)(6) 2020.As patient age (b)(6) was determined and as gender male as mentioned in the article.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following article was reviewed: ¿ antegrade common femoral artery access site closure using the manta vascular closure device¿ published by wouter stomp in the radiology case reports volume 15, issue 11, november 2020, pages 2205-2207.In antegrade peripheral endovascular procedures, the use of covered stents may require a large sheath size, which precludes the use of regular closure devices.The manta vascular closure device is a collagen plug-based vascular closure device for large bore percutaneous arterial interventions, which is normally used to close retrograde vascular access sites.A successful antegrade common femoral access site closure with the manta vascular closure device was described.Use of the manta vascular closure device simplifies large-bore antegrade common femoral artery access and avoids the need for surgical artery cutdown.The following complication was reported: a (b)(6) male patient with a popliteal artery aneurysm was treated by percutaneous endovascular stentgraft placement with 2 overlapping gore® viabahn® endoprostheses with propaten bioactive surface.The post-procedural period was complicated by acute stentgraft thrombosis, which resolved after intra-arterial thrombolysis.
 
Manufacturer Narrative
H6 evaluation codes investigation findings refers to the product history review: a review of the manufacturing records indicated the lot met all pre-release manufacturing specifications.The device remains implanted in the patient, therefore a device evaluation could not be performed.Neither clinical images enabling direct assessment of product performance nor the product itself were returned for evaluation.The physician stated it could well be that the stents occluded because the patient had bent his knee too much and too long (during gardening).This caused kinking and thereby occlusion of the stent, but he is not sure, as he cannot find written information on that.With the information reported to gore this investigation is considered complete, the cause of the complaint was unable to be determined, investigation conclusion code 22 was included because thrombosis is a known inherent risk of the device, and code 4310 was added as a possible cause because the physician reported the patient had bent his knee too much and too long (during gardening).Per the physician this caused kinking and thereby occlusion of the stent, but this could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12347343
MDR Text Key267441330
Report Number2017233-2021-02294
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeNL
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/06/2021
Device Catalogue NumberPAH111002E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/14/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/07/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexMale
Patient Weight80 KG
-
-